The reproductive-cell cycle theory of aging: An update

Experimental Gerontology

Volumn 46, Issue 2-3, 2011, Pages 100-107

  Atwood, Craig S ^a,b,c   Bowen, Richard L ^d  

^a GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EDITH COWAN UNIVERSITY   (Australia)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age related diseases; Aging; Andropause; Cell cycle re entry; Dyotic signaling; Endocrine dyscrasia; Hormone replacement therapy; Hypothalamic pituitary gonadal axis; Menopause; Reproductive hormones; Senescence

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ANDROPAUSE; ARTICLE; BODY SIZE; CELL CYCLE REGULATION; CEREBROVASCULAR DISEASE; DEMENTIA; EMBRYO DEVELOPMENT; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; FERTILITY; GROWTH RATE; HORMONAL REGULATION; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; ISCHEMIC HEART DISEASE; LIFESPAN; LONGEVITY; MALIGNANT NEOPLASTIC DISEASE; MENOPAUSE; NONHUMAN; OSTEOPOROSIS; PLEIOTROPY; PRIORITY JOURNAL; REPRODUCTION; SENESCENCE; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; GONADAL HORMONES; HUMANS; HYPOTHALAMIC HORMONES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY HORMONES; REPRODUCTION;

ANIMALIA;

EID: 78751706004     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.09.007     Document Type: Article

References (104)

1. Albright F., Smith P., Richardson A. Postmenopausal osteoporosis. Jama 1941, 116:2465-2474.
2. Arantes-Oliveira N., Apfeld J., Dillin A., Kenyon C. Regulation of life-span by germ-line stem cells in Caenorhabditis elegans. Science 2002, 295:502-505.
3. Asashima M., Michiue T., Kurisaki A. Elucidation of the role of activin in organogenesis using a multiple organ induction system with amphibian and mouse undifferentiated cells in vitro. Dev. Growth Differ. 2008, 50(Suppl 1):S35-S45.
4. Atwood C., Vadakkadath Meethal S., 2011. Gonadotropins and progestogens: obligatory developmental functions during early embryogenesis and their role in adult neurogenesis, neuroregeneration, and neurodegeneration. In Gravanis A.G., Mellon, S.H. (Eds.), Hormones in Neurodegeneration, Neuroprotection, and Neurogenesis. WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
5. Atwood C.S., Ikeda M., Vonderhaar B.K. Involution of mouse mammary glands in whole organ culture: a model for studying programmed cell death. Biochem. Biophys. Res. Commun. 1995, 207:860-867.
6. Atwood C.S., Hovey R.C., Glover J.P., Chepko G., Ginsburg E., Robison W.G., Vonderhaar B.K. Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J. Endocrinol. 2000, 167:39-52.
7. Atwood C.S., Barzilai N., Bowen R.L., Brown-Borg H.M., Jarrard D.F., Fu V.X., Heilbronn L.K., Ingram D.K., Ravussin E., Schwartz R.S., et al. Pennington scientific symposium on mechanisms and retardation of aging. Exp. Gerontol. 2003, 38:1217-1226.
8. Atwood C.S., Meethal S.V., Liu T., Wilson A.C., Gallego M., Smith M.A., Bowen R.L. Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence. J. Neuropathol. Exp. Neurol. 2005, 64:93-103.
9. Bake S., Sohrabji F. 17beta-estradiol differentially regulates blood-brain barrier permeability in young and aging female rats. Endocrinology 2004, 145:5471-5475.
10. Barnes A.I., Boone J.M., Jacobson J., Partridge L., Chapman T. No extension of lifespan by ablation of germ line in Drosophila. Proc. Biol. Sci. 2006, 273:939-947.
11. Belanger A., Candas B., Dupont A., Cusan L., Diamond P., Gomez J.L., Labrie F. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J. Clin. Endocrinol. Metab. 1994, 79:1086-1090.
12. Berndt S., Perrier d'Hauterive S., Blacher S., Pequeux C., Lorquet S., Munaut C., Applanat M., Herve M.A., Lamande N., Corvol P., et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J. 2006, 20:2630-2632.
13. Berndt S., Blacher S., Perrier d'Hauterive S., Thiry M., Tsampalas M., Cruz A., Pequeux C., Lorquet S., Munaut C., Noel A., et al. Chorionic gonadotropin stimulation of angiogenesis and pericyte recruitment. J. Clin. Endocrinol. Metab. 2009, 94:4567-4574.
14. Boepple P.A., Hayes F.J., Dwyer A.A., Raivio T., Lee H., Crowley W.F., Pitteloud N. Relative roles of inhibin B and sex steroids in the negative feedback regulation of follicle-stimulating hormone in men across the full spectrum of seminiferous epithelium function. J. Clin. Endocrinol. Metab. 2008, 93:1809-1814.
15. Bowen R.L., Atwood C.S. Living and dying for sex. A theory of aging based on the modulation of cell cycle signaling by reproductive hormones. Gerontology 2004, 50:265-290.
16. Bowen R.L., Isley J.P., Atkinson R.L. An association of elevated serum gonadotropin concentrations and Alzheimer disease?. J. Neuroendocrinol. 2000, 12:351-354.
17. Bowen R.L., Smith M.A., Harris P.L., Kubat Z., Martins R.N., Castellani R.J., Perry G., Atwood C.S. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J. Neurosci. Res. 2002, 70:514-518.
18. Bowen R.L., Verdile G., Liu T., Parlow A.F., Perry G., Smith M.A., Martins R.N., Atwood C.S. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J. Biol. Chem. 2004, 279:20539-20545.
19. Bowen R.L., Beaird H., Atwood C.S., Smith M.A., Rimm A.A. Men treated for prostate cancer have a decreased incidence of dementia. 9th International Congress on AD 2004.
20. Bryan K.J., Mudd J.C., Richardson S.L., Chang J., Lee H.G., Zhu X., Smith M.A., Casadesus G. Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits. J. Neurochem. 2010, 112:870-881.
21. Cargill S.L., Carey J.R., Muller H.G., Anderson G. Age of ovary determines remaining life expectancy in old ovariectomized mice. Aging Cell 2003, 2:185-190.
22. Carwile E., Wagner A.K., Crago E., Alexander S.A. Estrogen and stroke: a review of the current literature. J. Neurosci. Nurs. 2009, 41:18-25. quiz 26-17.
23. Cole L.A. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod. Biol. Endocrinol. 2009, 7:8.
24. D'Amico A.V., Braccioforte M.H., Moran B.J., Chen M.H. Luteinizing-hormone releasing hormone therapy and the risk of death from Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2010, 24:85-89.
25. Dubey R.K., Imthurn B., Barton M., Jackson E.K. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 2005, 66:295-306.
26. Elwan O., Abdallah M., Issa I., Taher Y., el-Tamawy M. Hormonal changes in cerebral infarction in the young and elderly. J. Neurol. Sci. 1990, 98:235-243.
27. Hypothalamus Pituitary and Aging 1976, Springfield, Illinois. A. Everitt, J.A. Burgess (Eds.).
28. Fernandez-Balsells M.M., Murad M.H., Lane M., Lampropulos J.F., Albuquerque F., Mullan R.J., Agrwal N., Elamin M.B., Gallegos-Orozco J.F., Wang A.T., et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2010, 95:2560-2575.
29. Fiddes J.C., Talmadge K. Structure, expression, and evolution of the genes for the human glycoprotein hormones. Recent Prog. Horm. Res. 1984, 40:43-78.
30. Folkerd E.J., Dowsett M. Influence of sex hormones on cancer progression. J. Clin. Oncol. 2010, 28:4038-4044.
31. Fournier A., Berrino F., Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res. Treat. 2008, 107:103-111.
32. Frye C.A., Walf A.A. Progesterone reduces depression-like behavior in a murine model of Alzheimer's Disease. Age (Dordr) 2009, 31:143-153.
33. Gallego M.J., Porayette P., Kaltcheva M., Bowen R.L., Vadakkadath Meethal S., Atwood C.S. Trophoblastic hormones direct early human embryogenesis 2008, Available from Nature Precedings http://hdl.handle.net/10101/npre.2008.2671.1.
34. Gallego M.J., Porayette P., Kaltcheva M.M., Meethal S.V., Atwood C.S. Opioid and progesterone signaling is obligatory for early human embryogenesis. Stem Cells Dev. 2009, 18:737-740.
35. Gleason C.E., Cholerton B., Carlsson C.M., Johnson S.C., Asthana S. Neuroprotective effects of female sex steroids in humans: current controversies and future directions. Cell. Mol. Life Sci. 2005, 62:299-312.
36. Greer E.L., Maures T.J., Hauswirth A.G., Green E.M., Leeman D.S., Maro G.S., Han S., Banko M.R., Gozani O., Brunet A. Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans. Nature 2010, 466(7304):383-387.
37. Hawken P.A., Jorre T.J., Rodger J., Esmaili T., Blache D., Martin G.B. Rapid induction of cell proliferation in the adult female ungulate brain (Ovis aries) associated with activation of the reproductive axis by exposure to unfamiliar males. Biol. Reprod. 2009, 80:1146-1151.
38. Helle S., Lummaa V., Jokela J. Sons reduced maternal longevity in preindustrial humans. Science 2002, 296:1085.
39. Helle S., Lummaa V., Jokela J. Are reproductive and somatic senescence coupled in humans? Late, but not early, reproduction correlated with longevity in historical Sami women. Proc. Biol. Sci. 2005, 272:29-37.
40. Hsin H., Kenyon C. Signals from the reproductive system regulate the lifespan of C. elegans. Nature 1999, 399:362-366.
41. Jacobsen B.K., Oda K., Knutsen S.F., Fraser G.E. Age at menarche, total mortality and mortality from ischaemic heart disease and stroke: the Adventist Health Study, 1976-88. Int. J. Epidemiol. 2009, 38:245-252.
42. Keating N.L., O'Malley A.J., Freedland S.J., Smith M.R. Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. J. Natl. Cancer Inst. 2010, 102:39-46.
43. Khosla S. Pathogenesis of osteoporosis. Transl. Endocrinol. Metab. 2010, 1:55-86.
44. Lakshman R., Forouhi N.G., Sharp S.J., Luben R., Bingham S.A., Khaw K.T., Wareham N.J., Ong K.K. Early age at menarche associated with cardiovascular disease and mortality. J. Clin. Endocrinol. Metab. 2009, 94:4953-4960.
45. Lamote I., Meyer E., Massart-Leen A.M., Burvenich C. Sex steroids and growth factors in the regulation of mammary gland proliferation, differentiation, and involution. Steroids 2004, 69:145-159.
46. Larson P., Kronenberg H., Melmed S., Polonsky K. Williams Textbook of Endocrinology 2003, Saunders, Philadelphia, PA.
47. Lee H.G., Chen Q., Wolfram J.A., Richardson S.L., Liner A., Siedlak S.L., Zhu X., Ziats N.P., Fujioka H., Felsher D.W., et al. Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure. PLoS ONE 2009, 4:e7172.
48. Lee J.S., Yaffe K., Lui L.Y., Cauley J., Taylor B., Browner W., Cummings S. Prospective study of endogenous circulating estradiol and risk of stroke in older women. Arch. Neurol. 2010, 67:195-201.
49. Lei Z.M., Reshef E., Rao V. The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. J. Clin. Endocrinol. Metab. 1992, 75:651-659.
50. Licht P., Russu V., Lehmeyer S., Moll J., Siebzehnrubl E., Wildt L. Intrauterine microdialysis reveals cycle-dependent regulation of endometrial insulin-like growth factor binding protein-1 secretion by human chorionic gonadotropin. Fertil. Steril. 2002, 78:252-258.
51. Lind T., Cameron E.H., Hunter W.M. Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy. Br. J. Obstet. Gynaecol. 1978, 85:138-141.
52. Lindsay R., Hart D.M., Aitken J.M., MacDonald E.B., Anderson J.B., Clarke A.C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976, 307:1038-1041.
53. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
54. Mak G.K., Enwere E.K., Gregg C., Pakarainen T., Poutanen M., Huhtaniemi I., Weiss S. Male pheromone-stimulated neurogenesis in the adult female brain: possible role in mating behavior. Nat. Neurosci. 2007, 10:1003-1011.
55. Manly J.J., Merchant C.A., Jacobs D.M., Small S.A., Bell K., Ferin M., Mayeux R. Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology 2000, 54:833-837.
56. Mason J.B., Cargill S.L., Anderson G.B., Carey J.R. Transplantation of young ovaries to old mice increased life span in transplant recipients. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64:1207-1211.
57. Mercuro G., Zoncu S., Cherchi A., Rosano G. Can menopause be considered an independent risk factor for cardiovascular disease?. Ital. Heart J. 2001, 10:719-727.
58. Miyaura C., Toda K., Inada M., Ohshiba T., Matsumoto C., Okada T., Ito M., Shizuta Y., Ito A. Sex- and age-related response to aromatase deficiency in bone. Biochem. Biophys. Res. Commun. 2001, 280:1062-1068.
59. Nakamura T., Imai Y., Matsumoto T., Sato S., Takeuchi K., Igarashi K., Harada Y., Azuma Y., Krust A., Yamamoto Y., et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 2007, 130:811-823.
60. Nedelec C., Ragot S., Irani J., Pires C., Gil R., Dore B. Effects by androgen suppression with luteinizing hormone on cognitive functions in men treated for cancer of prostate. Prog. Urol. 2009, 19:47-53.
61. Nilsen J., Morales A., Brinton R.D. Medroxyprogesterone acetate exacerbates glutamate excitotoxicity. Gynecol. Endocrinol. 2006, 22:355-361.
62. Ossewaarde M.E., Bots M.L., Verbeek A.L., Peeters P.H., van der Graaf Y., Grobbee D.E., van der Schouw Y.T. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 2005, 16:556-562.
63. Paganini-Hill A., Corrada M.M., Kawas C.H. Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study. Menopause 2006, 13:12-18.
64. Parker W.H., Broder M.S., Chang E., Feskanich D., Farquhar C., Liu Z., Shoupe D., Berek J.S., Hankinson S., Manson J.E. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet. Gynecol. 2009, 113:1027-1037.
65. Parsa P., Parsa B. Effects of reproductive factors on risk of breast cancer: a literature review. Asian Pac. J. Cancer Prev. 2009, 10:545-550.
66. Prins G.S., Birch L., Tang W.Y., Ho S.M. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol 2007, 23:374-382.
67. Prior J.C. Progesterone as a bone-trophic hormone. Endocr. Rev. 1990, 11:386-398.
68. Randolph J.F., Sowers M., Bondarenko I.V., Harlow S.D., Luborsky J.L., Little R.J. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J. Clin. Endocrinol. Metab. 2004, 89:1555-1561.
69. Report CNVS National Vital Statistics Report CDC National Vital Statistics Report Vol. 57, No. 14 2009.
70. Rocca W.A., Grossardt B.R., de Andrade M., Malkasian G.D., Melton L.J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006, 7:821-828.
71. Rogers P.A., Donoghue J.F., Walter L.M., Girling J.E. Endometrial angiogenesis, vascular maturation, and lymphangiogenesis. Reprod. Sci. 2009, 16:147-151.
72. Rubin P., Williams J.P., Devesa S.S., Travis L.B., Constine L.S. Cancer genesis across the age spectrum: associations with tissue development, maintenance, and senescence. Semin. Radiat. Oncol. 2010, 20:3-11.
73. Russo I.H., Russo J. Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res. 2007, 174:111-130.
74. Salpeter S.R., Walsh J.M., Greyber E., Ormiston T.M., Salpeter E.E. Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J. Gen. Intern. Med. 2004, 19:791-804.
75. Santen R.J., Allred D.C., Ardoin S.P., Archer D.F., Boyd N., Braunstein G.D., Burger H.G., Colditz G.A., Davis S.R., Gambacciani M., et al. Postmenopausal hormone therapy: an endocrine society scientific statement. J. Clin. Endocrinol. Metab. 2010, 95(7 Suppl 1):s1-s66.
76. Sanyal A., Hoey K.A., Modder U.I., Lamsam J.L., McCready L.K., Peterson J.M., Achenbach S.J., Oursler M.J., Khosla S. Regulation of bone turnover by sex steroids in men. J. Bone Miner. Res. 2008, 23:705-714.
77. Sauter C.N., McDermid R.L., Weinberg A.L., Greco T.L., Xu X., Murdoch F.E., Fritsch M.K. Differentiation of murine embryonic stem cells induces progesterone receptor gene expression. Exp. Cell Res. 2005, 311:251-264.
78. Sherwin B.B., Tulandi T. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J. Clin. Endocrinol. Metab. 1996, 81:2545-2549.
79. Simon A.F., Shih C., Mack A., Benzer S. Steroid control of longevity in Drosophila melanogaster. Science 2003, 299:1407-1410.
80. Simon D.P., Vadakkadath Meethal S., Wilson A.C., Gallego M.J., Weinecke S.L., Bruce E., Lyons P.F., Haasl R.J., Bowen R.L., Atwood C.S. Activin receptor signaling regulates prostatic epithelial cell adhesion and viability. Neoplasia 2009, 11:365-376.
81. Sims N.A., Dupont S., Krust A., Clement-Lacroix P., Minet D., Resche-Rigon M., Gaillard-Kelly M., Baron R. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone 2002, 30:18-25.
82. Smith K.R., Gagnon A., Cawthon R.M., Mineau G.P., Mazan R., Desjardins B. Familial aggregation of survival and late female reproduction. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64:740-744.
83. Soderqvist G., Isaksson E., von Schoultz B., Carlstrom K., Tani E., Skoog L. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am. J. Obstet. Gynecol. 1997, 176:123-128.
84. Sowers M.R., Jannausch M., McConnell D., Little R., Greendale G.A., Finkelstein J.S., Neer R.M., Johnston J., Ettinger B. Hormone predictors of bone mineral density changes during the menopausal transition. J. Clin. Endocrinol. Metab. 2006, 91:1261-1267.
85. Stein D.G., Wright D.W., Kellermann A.L. Does progesterone have neuroprotective properties?. Ann. Emerg. Med. 2008, 51:164-172.
86. Sun L., Peng Y., Sharrow A.C., Iqbal J., Zhang Z., Papachristou D.J., Zaidi S., Zhu L.L., Yaroslavskiy B.B., Zhou H., et al. FSH directly regulates bone mass. Cell 2006, 125:247-260.
87. Tan R.S., Pu S.J. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male 2003, 6:13-17.
88. Telegdy G., Tanaka M., Schally A.V. Effects of the LHRH antagonist Cetrorelix on the brain function in mice. Neuropeptides 2009, 43:229-234.
89. Toth P., Lukacs H., Gimes G., Sebestyen A., Pasztor N., Paulin F., Rao C.V. Clinical importance of vascular LH/hCG receptors-a review. Reprod. Biol. 2001, 1:5-11.
90. Vadakkadath Meethal S., Atwood C.S. The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain. Cell. Mol. Life Sci. 2005, 62:257-270.
91. Vadakkadath Meethal S., Gallego M.J., Haasl R.J., Petras S.J., Sgro J.Y., Atwood C.S. Identification of a gonadotropin-releasing hormone receptor orthologue in Caenorhabditis elegans. BMC Evol. Biol. 2006, 6:103.
92. Verdile G., Yeap B.B., Clarnette R.M., Dhaliwal S., Burkhardt M.S., Chubb S.A., De Ruyck K., Rodrigues M., Mehta P.D., Foster J.K., et al. Luteinizing hormone levels are positively correlated with plasma amyloid-beta protein levels in elderly men. J. Alzheimers Dis. 2008, 14:201-208.
93. Wang J.M., Johnston P.B., Ball B.G., Brinton R.D. The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J. Neurosci. 2005, 25:4706-4718.
94. Wang W., Bu B., Xie M., Zhang M., Yu Z., Tao D. Neural cell cycle dysregulation and central nervous system diseases. Prog. Neurobiol. 2009, 89:1-17.
95. Wilson A.C., Meethal S.V., Bowen R.L., Atwood C.S. Leuprolide acetate: a drug of diverse clinical applications. Expert Opin. Investig. Drugs 2007, 16:1851-1863.
96. Wilson A.C., Clemente L., Liu T., Bowen R.L., Meethal S.V., Atwood C.S. Reproductive hormones regulate the selective permeability of the blood-brain barrier. Biochim. Biophys. Acta 2008, 1782:401-407.
97. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., Salomone J.P., Dent L.L., Harris O.A., Ander D.S., et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 2007, 49:391-402. 402 e391-392.
98. Wu Y., Torchia J., Yao W., Lane N.E., Lanier L.L., Nakamura M.C., Humphrey M.B. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. PLoS ONE 2007, 2:e586.
99. Xia X., Zhang S.C. Differentiation of neuroepithelia from human embryonic stem cells. Methods Mol. Biol. 2009, 549:51-58.
100. Yeap B.B. Androgens and cardiovascular disease. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17:269-276.
101. Zaidi M., Iqbal J., Blair H.C., Zallone A., Davies T., Sun L. Paradigm shift in the pathophysiology of postmenopausal and thyrotoxic osteoporosis. Mt. Sinai J. Med. 2009, 76:474-483.
102. Zhuang L.Z., Li R.H. Study on reproductive endocrinology of human placenta (II)-Hormone secreting activity of cytotrophoblast cells. Sci. China B 1991, 34:1092-1097.
103. Zupanc G.K. Neurogenesis, cell death and regeneration in the adult gymnotiform brain. J. Exp. Biol. 1999, 202:1435-1446.
104. Zygmunt M., Herr F., Keller-Schoenwetter S., Kunzi-Rapp K., Munstedt K., Rao C.V., Lang U., Preissner K.T. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J. Clin. Endocrinol. Metab. 2002, 87:5290-5296.